Abstract

The aim of the study was to evaluate the interleukin-17 (IL-17) plasma level in HIV-1-infected patients and its relation to central obesity. Methods: Eighty-four HIV-1-infected patients [42 with visceral obesity (group A) and 42 without visceral obesity (group B)] and 46 HIV-negative subjects [23 with visceral obesity (group C) and 23 without visceral obesity (group D)] were enrolled in the study. Sonographic measurements of perirenal fat diameter/body mass index (PRFD/BMI) were used to assess visceral adipose tissue thickness. Results: HIV-1-infected patients had higher plasma levels of IL-17 than HIV-negative subjects [837.8±260pg/mL (mean ± standard deviation) vs. 395.3±138.6pg/mL, respectively; P<0.001]. Furthermore, HIV-1-infected patients with a diagnosis of visceral obesity had lower levels of IL-17 than HIV-infected lean patients (756.9±282.9pg/mL vs. 918.7±208.4pg/mL, respectively; P<0.01). IL-17 (r=-0.21; P=0.03) and waist circumference (r=0.48; P<0.001) were significantly associated with visceral adipose tissue thickness. A negative correlation of IL-17 (r=-0.23; P<0.001) with PRFD/BMI was found. Conclusions: This study suggests a linear negative association between IL-17 and visceral adipose tissue thickness. © 2012 British HIV Association.

Autore Pugliese

• Zizza Antonella

Tutti gli autori

• Zizza A.; Guido M.; Grima P.

Titolo volume/Rivista

HIV medicine

Anno di pubblicazione

2012

ISSN

1468-1293

ISBN

Non Disponibile

Numero di citazioni Wos

Nessuna citazione

Ultimo Aggiornamento Citazioni

Non Disponibile

Numero di citazioni Scopus

Non Disponibile

Ultimo Aggiornamento Citazioni

Non Disponibile

Settori ERC

Non Disponibile

Codici ASJC

Non Disponibile